Lummis Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.8K Buy
253
+10
+4% +$807 0.01% 108
2026
Q1
$21.1K Hold
243
0.01% 107
2025
Q4
$23.3K Buy
+243
New +$23.6K 0.01% 102
2025
Q3
Sell
-213
Closed -$18.6K 163
2025
Q2
$18.6K Hold
213
0.01% 102
2025
Q1
$19.1K Hold
213
0.01% 102
2024
Q4
$17K Hold
213
0.02% 77
2024
Q3
$19.2K Hold
213
0.02% 80
2024
Q2
$16.8K Hold
213
0.02% 79
2024
Q1
$18.6K Hold
213
0.02% 80
2023
Q4
$17.5K Buy
+213
New +$16.2K 0.01% 107

Other funds holding MDT

Lummis Asset Management's MDT Position: Q2 2026 in Review

Lummis Asset Management increased its Medtronic (MDT) stake by 4.1% in Q2 2026, buying an estimated $807 and bringing the position to 253 shares worth $19.8K. The position accounts for 0.01% of the portfolio, ranked #108.

Lummis Asset Management first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. The position peaked at $23.3K in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Lummis Asset Management held 253 shares of Medtronic worth $19.8K as of Q2 2026.
  • Lummis Asset Management bought 10 Medtronic shares in Q2 2026, an estimated $807.
  • Medtronic made up 0.01% of Lummis Asset Management's portfolio in Q2 2026, its #108 holding.
  • Lummis Asset Management first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
  • Lummis Asset Management's Medtronic position peaked at $23.3K in Q4 2025.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Lummis Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.